{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:29:45Z","timestamp":1791073785854,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1067\/mai.2001.118796","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"839-846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis"],"prefix":"10.1067","volume":"108","author":[{"given":"Axel","family":"Trautmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcbeccel","family":"Akdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schmid-Grendelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Disch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-B.","family":"Br\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Blaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezmi A.","family":"Akdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mai.2001.118796_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0091-6749(83)90546-8","article-title":"Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies","volume":"71","author":"Leung","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2001.118796_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0167-5699(97)01186-9","article-title":"Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity","volume":"19","author":"Grabbe","year":"1998","journal-title":"Immunol Today"},{"key":"10.1067\/mai.2001.118796_bib3","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1084\/jem.181.5.1935","article-title":"Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen","volume":"181","author":"Santamaria Babi","year":"1995","journal-title":"J Exp Med"},{"key":"10.1067\/mai.2001.118796_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0952-7915(00)00156-4","article-title":"Immune regulation in atopic dermatitis","volume":"12","author":"Akdis","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1067\/mai.2001.118796_bib5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1067\/mai.2000.106484","article-title":"Atopic dermatitis: new insights and opportunities for therapeutic intervention","volume":"105","author":"Leung","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2001.118796_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0167-5699(98)01285-7","article-title":"A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis","volume":"19","author":"Grewe","year":"1998","journal-title":"Immunol Today"},{"key":"10.1067\/mai.2001.118796_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI9199","article-title":"T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis","volume":"106","author":"Trautmann","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1067\/mai.2001.118796_bib8","unstructured":"Trautmann A, Altznauer F, Akdis M, Simon HU, Disch R, Br\u00f6cker EB, et al. The differential fate of cadherins during T cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J Invest Dermatol. In press."},{"issue":"suppl 58","key":"10.1067\/mai.2001.118796_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1398-9995.1999.tb04748.x","article-title":"Therapeutic perspectives in atopic dermatitis","volume":"54","author":"Leung","year":"1999","journal-title":"Allergy"},{"key":"10.1067\/mai.2001.118796_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1034\/j.1600-0536.2000.043006317.x","article-title":"An overview of the efficiacy of topical cortico-steroids in experimental human nickel contact dermatitis","volume":"43","author":"Levin","year":"2000","journal-title":"Contact Dermatitis"},{"key":"10.1067\/mai.2001.118796_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000424237","article-title":"Acute irritant dermatitis: effect of short-term topical corticoid treatment","volume":"22","author":"Berardesca","year":"1995","journal-title":"Curr Probl Dermatol"},{"key":"10.1067\/mai.2001.118796_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000018065","article-title":"Comparison of two formulations of cyclosporin A treatment of severe atopic dermatitis. A double-blind, single-centre, cross-over pilot study","volume":"198","author":"Zurbriggen","year":"1999","journal-title":"Dermatology"},{"key":"10.1067\/mai.2001.118796_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.1996.tb00705.x","article-title":"Treatment of severe atopic dermatitis in childhood with cyclosporin","volume":"135","author":"Zaki","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1067\/mai.2001.118796_bib14","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/S0091-6749(99)70055-2","article-title":"Treatment of atopic dermatitis: role of tacrolimus as a topical noncorticosteroidal therapy","volume":"104","author":"Fleischer","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1067\/mai.2001.118796_bib15","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1067\/mjd.2001.109816","article-title":"2001. Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis","volume":"44","author":"Bekersky","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mai.2001.118796_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2133.2000.03377.x","article-title":"The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature","volume":"142","author":"Jolles","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1067\/mai.2001.118796_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(82)70001-5","article-title":"Atopic dermatitis","volume":"6","author":"Hanifin","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mai.2001.118796_bib18","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1002\/1521-4141(2000012)30:12<3533::AID-IMMU3533>3.0.CO;2-5","article-title":"Expression of cutaneous lymphocyte-associated antigen on human CD4(+) and CD8(+) Th2 cells","volume":"30","author":"Akdis","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1067\/mai.2001.118796_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.119.3.493","article-title":"Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation","volume":"119","author":"Gavrieli","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1067\/mai.2001.118796_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1023\/A:1026456229688","article-title":"Human keratinocytes maintain reversible anti-apoptotic defenses in vivo and in vitro","volume":"2","author":"Norris","year":"1997","journal-title":"Apoptosis"},{"key":"10.1067\/mai.2001.118796_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4400207","article-title":"Apoptotic DNA fragmentation is detected by a semiquantitative ligation-mediated PCR of blunt DNA ends","volume":"4","author":"Staley","year":"1997","journal-title":"Cell Death Diff"},{"key":"10.1067\/mai.2001.118796_bib22","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJM199912093412407","article-title":"Inflammatory skin diseases, T cells, and immune surveillance","volume":"341","author":"Robert","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2001.118796_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2340\/0001555576371376","article-title":"Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema","volume":"76","author":"Granlund","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1067\/mai.2001.118796_bib24","first-page":"L921","article-title":"Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-\u03b3 and Fas","volume":"273","author":"Wen","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1067\/mai.2001.118796_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM199101313240501","article-title":"Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial","volume":"324","author":"Ellis","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2001.118796_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2133.1990.tb01848.x","article-title":"Time-dependent inhibition of growth of human ke-ratinocytes and fibroblasts by cyclosporin A: effect on keratinocytes at therapeutic blood levels","volume":"123","author":"Sharpe","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1067\/mai.2001.118796_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0167-5699(96)80599-8","article-title":"FK506 in the treatment of inflammatory skin disease: promises and perspectives","volume":"17","author":"Michel","year":"1996","journal-title":"Immunol Today"},{"key":"10.1067\/mai.2001.118796_bib28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0952-7915(96)80090-2","article-title":"Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide","volume":"8","author":"Brazelton","year":"1996","journal-title":"Curr Opin Immunol"},{"issue":"suppl","key":"10.1067\/mai.2001.118796_bib29","first-page":"3","article-title":"Mechanisms of action of intravenous immune globulin in immune-mediated diseases","volume":"104","author":"Mouthon","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mai.2001.118796_bib30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immune globulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1067\/mai.2001.118796_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/clin.1994.1186","article-title":"Suppression of cytokine-dependent human T cell proliferation by intravenous immunoglobulin","volume":"73","author":"Amran","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1067\/mai.2001.118796_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/clin.1997.4329","article-title":"Posttranscriptional regulation of T cell IL-2 production by human pooled immunoglobulin","volume":"83","author":"Modiano","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1067\/mai.2001.118796_bib33","doi-asserted-by":"crossref","first-page":"11490","DOI":"10.1073\/pnas.94.21.11490","article-title":"Downregulation of interferon \u03b3-activated STAT1 by UV light","volume":"94","author":"Aragane","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"suppl 3","key":"10.1067\/mai.2001.118796_bib34","first-page":"35","article-title":"Theophylline and airway inflammation","volume":"28","author":"Rabe","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2001.118796_bib35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.189.5.779","article-title":"Cytotoxicity is mandatory for CD8 T cell-mediated contact hypersensitivity","volume":"189","author":"Kehren","year":"1999","journal-title":"J Exp Med"},{"key":"10.1067\/mai.2001.118796_bib36","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.4049\/jimmunol.165.6.3058","article-title":"Disparate cytotoxic activity of nickel-specific CD8 and CD4 cell subsets against keratinocytes","volume":"165","author":"Traidl","year":"2000","journal-title":"J Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674901740407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674901740407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:48:12Z","timestamp":1758775692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674901740407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0091674901740407"],"URL":"https:\/\/doi.org\/10.1067\/mai.2001.118796","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mai.2001.118796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}